- Home
- EARN vs TVGN Comparison
EARN vs TVGN Comparison
Compare EARN & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EARN
- TVGN
- Stock Information
- Founded
- EARN 2012
- TVGN 2020
- Country
- EARN United States
- TVGN United States
- Employees
- EARN N/A
- TVGN N/A
- Industry
- EARN Real Estate Investment Trusts
- TVGN Blank Checks
- Sector
- EARN Real Estate
- TVGN Finance
- Exchange
- EARN Nasdaq
- TVGN Nasdaq
- Market Cap
- EARN 187.6M
- TVGN 193.1M
- IPO Year
- EARN 2013
- TVGN N/A
- Fundamental
- Price
- EARN $5.77
- TVGN $1.25
- Analyst Decision
- EARN Buy
- TVGN Strong Buy
- Analyst Count
- EARN 2
- TVGN 1
- Target Price
- EARN $6.00
- TVGN $10.00
- AVG Volume (30 Days)
- EARN 245.0K
- TVGN 730.2K
- Earning Date
- EARN 08-11-2025
- TVGN 08-13-2025
- Dividend Yield
- EARN 16.67%
- TVGN N/A
- EPS Growth
- EARN N/A
- TVGN N/A
- EPS
- EARN N/A
- TVGN N/A
- Revenue
- EARN $35,893,000.00
- TVGN N/A
- Revenue This Year
- EARN $3.21
- TVGN N/A
- Revenue Next Year
- EARN $18.63
- TVGN N/A
- P/E Ratio
- EARN N/A
- TVGN N/A
- Revenue Growth
- EARN 43.30
- TVGN N/A
- 52 Week Low
- EARN $4.33
- TVGN $0.26
- 52 Week High
- EARN $7.20
- TVGN $3.09
- Technical
- Relative Strength Index (RSI)
- EARN 56.22
- TVGN 52.76
- Support Level
- EARN $5.68
- TVGN $1.20
- Resistance Level
- EARN $5.79
- TVGN $1.28
- Average True Range (ATR)
- EARN 0.07
- TVGN 0.06
- MACD
- EARN -0.01
- TVGN -0.00
- Stochastic Oscillator
- EARN 75.00
- TVGN 51.16
About EARN Ellington Residential Mortgage REIT of Beneficial Interest
Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on strong risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times of stress. It also leverages Ellington's proprietary technology, analytics and risk management systems to enhance underwriting and investment selection and to guide ongoing portfolio monitoring and surveillance.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.